Case Report: Nitrofurantoin-induced interstitial lung disease
نویسندگان
چکیده
منابع مشابه
a 2.5 months old girl with interstitial lung disease-a case report
Children interstitial lung (ChILD) disease is a large group of disorders with damage in alveolus and capillary. Although these disorders resemble ILD of adult in nomination, ChILD represents different pathologic and clinical patterns. A 2.5 months old girl, with failure to thrive and grunting and dyspnea, complained of staccato coughs without association with feeding, since she was 15 days o...
متن کاملNitrofurantoin-induced pulmonary fibrosis: a case report
INTRODUCTION Nitrofurantoin is a commonly used drug in the treatment and prevention of urinary tract infections. Many adverse effects of nitrofurantoin have been documented, including aplastic anemia, polyneuritis, and liver and pulmonary toxicity. CASE PRESENTATION We describe the clinical history and the autopsy findings in a 51-year-old woman with lung fibrosis of unknown etiology. She had...
متن کاملRecurrent nitrofurantoin-induced giant cell interstitial pneumonia: Case report and literature review
Giant cell interstitial pneumonia (GIP) is a rare form of chronic interstitial pneumonia typically associated with hard metal exposure. Only two cases of GIP induced by nitrofurantoin have been reported in the medical literature. We are reporting a case of recurrent nitrofurantoin-induced GIP. Although extremely rare, GIP needs to be included in the differential diagnosis in patients with chron...
متن کاملInterstitial lung disease associated to erlotinib treatment: a case report
INTRODUCTION Few cases of pulmonary toxicity related to epidermal growth factor receptor-targeted agents have been described. CASE PRESENTATION We report a case of a 63-year-old white male with stage IV non-small cell lung cancer treated with erlotinib who developed a interstitial lung disease. CONCLUSION Respiratory symptoms during treatment with erlotinib should alert clinicians to rule o...
متن کاملDrug Induced Interstitial Lung Disease
With an increasing number of therapeutic drugs, the list of drugs that is responsible for severe pulmonary disease also grows. Many drugs have been associated with pulmonary complications of various types, including interstitial inflammation and fibrosis, bronchospasm, pulmonary edema, and pleural effusions. Drug-induced interstitial lung disease (DILD) can be caused by chemotherapeutic agents,...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: F1000Research
سال: 2015
ISSN: 2046-1402
DOI: 10.12688/f1000research.6245.1